News | December 14, 2022
Balaxi conducts groundbreaking for its Rs 85 crore Hyderabad manufacturing facility
The investment will enable the company to enter European markets as well as enhance margins in current markets
The investment will enable the company to enter European markets as well as enhance margins in current markets
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Soluplus branded excipient play a critical role in enabling the drug development process for poorly soluble active pharmaceutical ingredients
Move to increase affordability and accessibility for heart failure patients across the country
This product is based on Osmotic Controlled Release Oral Delivery System technology
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
The JUMP-CP Consortium’s aim is to validate and scale up image-based drug discovery strategies by creating the world’s largest public cell imaging data set
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
The move will add new global talent to Cytel’s Strategic Consulting group
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
